Central Pacific Bank - Trust Division’s AbbVie ABBV Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45M	Sell	5,766 -4,628	-45%	-$996K	0.15%	142
2026 Q1	$2.26M	Sell	10,394 -3,158	-23%	-$701K	0.29%	90
2025 Q4	$3.1M	Sell	13,552 -29	-0.2%	-$6.61K	0.38%	58
2025 Q3	$3.14M	Sell	13,581 -261	-2%	-$53.1K	0.38%	63
2025 Q2	$2.57M	Buy	13,842 +5,662	+69%	+$1.05M	0.33%	80
2025 Q1	$1.71M	Sell	8,180 -227	-3%	-$44.1K	0.24%	111
2024 Q4	$1.49M	Sell	8,407 -5,375	-39%	-$988K	0.2%	125
2024 Q3	$2.72M	Buy	13,782 +2,256	+20%	+$421K	0.34%	65
2024 Q2	$1.98M	Sell	11,526 -2,877	-20%	-$477K	0.24%	95
2024 Q1	$2.6M	Buy	+14,403	New	+$2.48M	0.32%	66

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Central Pacific Bank - Trust Division's ABBV Position: Q2 2026 in Review

Central Pacific Bank - Trust Division reduced its AbbVie (ABBV) stake by 45% in Q2 2026, selling an estimated $996K and leaving 5,766 shares worth $1.45M. The position accounts for 0.15% of the portfolio, ranked #142.

Central Pacific Bank - Trust Division first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.14M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Central Pacific Bank - Trust Division held 5,766 shares of AbbVie worth $1.45M as of Q2 2026.
Central Pacific Bank - Trust Division sold 4,628 AbbVie shares in Q2 2026, an estimated $996K.
AbbVie made up 0.15% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #142 holding.
Central Pacific Bank - Trust Division first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
Central Pacific Bank - Trust Division's AbbVie position peaked at $3.14M in Q3 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.